The series is expected to include four smartphones: the Galaxy S25, Galaxy S25+, Galaxy S25 Ultra, and the Galaxy S25 Slim. Listen to Story Samsung to unveil Galaxy S25 series on Jan 22 Prices higher ...

through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.

The original Bifocal Lenses In Nearsighted Kids (BLINK) Study showed that having children with myopia wear high-add power multifocal contact lenses slows its progression. Now, new results from the ...

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers ...

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for ...

Summary: New research demonstrates that high-add multifocal contact lenses significantly slow myopia progression in children, with benefits that persist even after discontinuation. The lenses, ...

London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

Aspire IOLs address astigmatism, broadening treatable ranges in cataract surgery to <1.0D at the corneal plane. In the US, enVista Aspire is the first Low-Cyl toric IOL below 1.5D at the IOL plane, ...

efficient unfolding through Bausch + Lomb’s proprietary StableFlex™ Technology, which aids optic recovery. For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for ...